BioSpace News Archive

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) (“CNS” or the “Company”) today announced that over 100 patients have been enrolled in the Company’s potentially pivotal study with their lead product candidate, Berubicin.

Cerner Enviza, an Oracle company, along with John Snow Labs, are now helping support the U.S. Food and Drug Administration’s drug safety Sentinel Initiative.

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the date of the U.S. Food and Drug Administration’s Cellular, Tissue and Gene Therapies Advisory Committee meeting for the SRP-9001 (delandistrogene moxeparvovec) biologics license application (BLA) is May 12, 2023.

RS BioTherapeutics is pleased to announce that it has appointed pharmaceutical industry veteran Dean Hart as its Chief Executive Officer.

Athersys, Inc., a cell therapy and regenerative medicine company developing MultiStem® for critical care indications, announced it will host a business update conference call on April 20, 2023 at 11:00 a.m. Eastern Time.